NCT06900751View on ClinicalTrials.gov

A Study to Assess NEU-627 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Healthy

Interventions

DRUG

NEU-627

Investigational medicinal product

OTHER

Placebo

Placebo

Trial Locations (1)

1010

RECRUITING

New Zealand Clinical Research, Grafton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Neuron23 Inc.

INDUSTRY

NCT06900751 - A Study to Assess NEU-627 in Healthy Participants | Biotech Hunter | Biotech Hunter